CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

RAPPRapport Therapeutics, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $33.60 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$1.61B
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-08 · Ceesay Abraham (Chief Executive Officer) · SELL
  • 2026-10-01 · Gault Cheryl (Chief Operating Officer) · SELL
  • 2026-09-24 · Ceesay Abraham (Chief Executive Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders168
Shares held53,125,994
Value$2.14B
Percent of shares outstanding110.73%
As of quarter end2026-06-30
RECENT NEWS
  • Rapport Therapeutics CEO Abraham Ceesay sells $143,272 in stock
  • Rapport Therapeutics, Inc. (RAPP) Discusses RAP-219 Phase II Trial and Unmet Needs in Bipolar Mania - Slideshow
  • Why is Rapport Therapeutics stock sliding today?
  • Rapport Therapeutics at TD Cowen summit: bipolar data loom
  • Rapport Therapeutics: Great CNS Science, But The Valuation Prices In Significant Success
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS